Amplia Therapeutics Ltd.ASX: ATX

Response to ASX Price Query

· Issued by Amplia Therapeutics Ltd. via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Amplia Therapeutics Ltd. has responded to a price query from the ASX regarding recent trading activity in its securities, confirming it is not aware of any undisclosed information that could explain the trading changes. The company stated it is complying with the ASX Listing Rules and that its responses were authorized by the Managing Director. Amplia was asked to provide information by the ASX due to a significant price drop and increased trading volume of its shares.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/response-to-asx-price-query-925

Release

ABN 16 165 160 841 +61 (0) 3 9123 1140 | info@ampliatx.com Level 5, 90 William Street, Melbourne VIC 3000 Australia www.ampliatx.com 16 OCTOBER 2026 Response to ASX Price Query Amplia Therapeutics Limited (ASX:ATX;) (“Amplia” or the “Company”) refers to the Price Query letter received from...

Amplia Therapeutics Ltd. on 6ix

Earlier from Amplia Therapeutics

Later from Amplia Therapeutics

All Amplia Therapeutics news releases